Skip to main content
. 2022 Aug 17;14(16):3982. doi: 10.3390/cancers14163982

Figure 2.

Figure 2

Emergent prostate cancer biomarkers for urine, serum, and tissue samples have been developed and can be used for diagnostic, prognostic, or risk stratification purposes. Legend: EPI, ExoDx Prostate IntelliScore; MPS, MyProstateScore; PCA3, prostate cancer gene 3; PHI, Prostate Health Index; 4KScore, Four-Kallikrein test.